![](https://porib.com/wp-content/uploads/2021/07/journal_viral_hepatitis.jpg)
Forns X, Colom J, García-Retortillo M, Quer JC, Lens S, Martró E, Domínguez-Hernández R, Casado MA, Buti M
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
J Viral Hepat. 2021;00:1–4
MÁS INFORMACIÓN
![](https://porib.com/wp-content/uploads/2021/07/the_european_journal_of_hospital_pharmacy___science_and_practice.jpg)
Calleja MA, Albanell J, Aranda E, García-Foncillas J, Feliu A, Rivera F, Oyagüez I, Salinas-Ortega L, Soto J
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Eur J Hosp Pharm. doi:10.1136/ejhpharm-2021-002955
![](https://porib.com/wp-content/uploads/2021/07/Diabetes-Therapy-1.jpg)
Gomez-Peralta F, Mareque M, Muñoz A, Maderuelo M, Casado MA
Patient preferences for pharmacological diabetes treatment among people with diabetes in Spain – A discrete choice experiment
Diabetes Ther. 2022;13(1):75-87
![](https://porib.com/wp-content/uploads/2010/06/european_addiction_research.jpg)
Pascua FS, Muñoz A, Oraa R, Flórez G, Notario P, Seijo P, Gonzalvo B, Assaf C, Gómez M, Casado MA
Perception of a new prolonged-release buprenorphine formulation in patients with opioid use disorder. The PREDEPO study
European Addiction Research: Doi: DOI:10.1159/000520091
![](https://porib.com/wp-content/uploads/2022/03/Emergencias.jpg)
Moltó J, González J, Navarro C, Castro A, Presa M, Oyagüez I
Cribado dirigido del Virus de la Inmunodeficiencia Humana en los servicios de urgencias en España: análisis de las consecuencias epidemiológicas y económicas
Emergencias 2022;34:21-28
![](https://porib.com/wp-content/uploads/2021/07/revista_espanola_de_economia_de_la_salud.jpg)
Ferrando R, Belmonte-Serrano MA, Echave M, Espinoza N, Casado MA, Maratia S
Productividad laboral y doméstica con certolizumab pegol en pacientes con espondiloartritis axial no radiográfica en España: un análisis de costes
Rev Esp Econ Salud. 2021;V16(4):70-82
![](https://porib.com/wp-content/uploads/2021/07/the_european_journal_of_health_economics.jpg)
Alsina L, Montoro JB, Moral P, Neth O, Ortiz M, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MA, González-Granado LI
Cost-Minimization Analysis of Immunoglobulin Treatment of Primary Immunodeficiency Diseases in Spain
Eur J Health Econ. DOI: 10.1007/s10198-021-01378-x
![](https://porib.com/wp-content/uploads/2021/07/adicciones.jpg)
Pascual F, Muñoz A, Oraa F, Flórez G, Notario P, Seijo P, Gonzalvo B, Assaf C, Gómez M, Casado MA
Satisfacción y experiencia de pacientes en tratamiento con sustitutivos opiáceos en España. Estudio PREDEPO
Adicciones. Doi:10.1159/000520091
![](https://porib.com/wp-content/uploads/2022/03/life.jpg)
Marron SE, Tomas-Aragones L, Moncin-Torres CA, Gomez-Barrera M, Garcia-Latasa de Aranibar FJ
Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results
Life 2021; 11 (7), 617
![](https://porib.com/wp-content/uploads/2021/07/Act_far_terap.jpg)
Ferrando R, Rios E, Sastre JL, Gomez A, Echave M, Gomez-Barrera M, Oyagüez I, Salvador J, Sanchez R